ClinOne, a leading provider of Adaptive Experiences in clinical trials, announced it closed a $3 million Series A funding to accelerate the growth of its platform and broaden its reach to serve customers.

This latest round, led by Boulder Ventures, with participation from existing investors CU Healthcare Innovation Fund and First Trust Capital Partners, will continue to advance ClinOne's mission to offer flexible engagement solutions for all participants to support their clinical trial journey.